Gankyrin, also known as PSMD10, serves as an oncogene in various malignant cancers, including hepatocellular carcinoma, colorectal cancer, gastric cancer, prostate cancer, ovarian cancer, and cholangiocarcinoma3–5. This evidence concerns the gene PSMD10 and prostate cancer.